Routine Imaging for Diffuse Large B-Cell Lymphoma in First Complete Remission Does Not Improve Post-Treatment Survival: A Danish-Swedish Population-Based Study.

Tarec Christoffer El-Galaly, Lasse Hjort Jakobsen, Martin Hutchings, Peter de Nully Brown, Herman Nilsson-Ehle, Erzsébet Szekely, Karen Juul Mylam, Viktoria Hjalmar, Hans Erik Johnsen, Martin Bøgsted, Mats Jerkeman

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review

Sammanfattning

Routine imaging for diffuse large B-cell lymphoma (DLBCL) in first complete remission (CR) is controversial and plays a limited role in detecting relapse. This population-based study compared the survival of Danish and Swedish patients with DLBCL for whom traditions for routine imaging have been different.
Originalspråkengelska
Sidor (från-till)3993-3998
TidskriftJournal of Clinical Oncology
Volym33
Nummer34
DOI
StatusPublished - 2015

Ämnesklassifikation (UKÄ)

  • Cancer och onkologi

Fingeravtryck

Utforska forskningsämnen för ”Routine Imaging for Diffuse Large B-Cell Lymphoma in First Complete Remission Does Not Improve Post-Treatment Survival: A Danish-Swedish Population-Based Study.”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här